{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:37:04Z","timestamp":1791250624681,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T00:00:00Z","timestamp":1448409600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1934-1","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T20:26:39Z","timestamp":1448483199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Understanding of BRCA VUS genetic results by breast cancer specialists"],"prefix":"10.1186","volume":"15","author":[{"given":"B. K.","family":"Eccles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Copson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Maishman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. M.","family":"Eccles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,25]]},"reference":[{"key":"1934_CR1","first-page":"265","volume":"S6","author":"DF Easton","year":"1995","unstructured":"Easton DF, Ford D, Bishop DT, Breast Cancer linkage Consortium. Breast and Ovarian Cancer Incidence in BRCA1-Mutation Carriers. Am J Hum Genet. 1995;S6:265\u201371.","journal-title":"Am J Hum Genet"},{"key":"1934_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swenson J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66\u201371.","journal-title":"Science"},{"key":"1934_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/science.7939630","volume":"266","author":"PA Futreal","year":"1994","unstructured":"Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C. BRCA1 mutations in primary breast and ovarian cancers. Science. 1994;266:120\u20132.","journal-title":"Science"},{"key":"1934_CR4","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s13058-014-0442-6","volume":"16","author":"DG Evans","year":"2014","unstructured":"Evans DG, Barwell J, Eccles DM, Collins A, Izatt L, Jacobs C, et al. The Angelina Jolie effect: How high celebrity profile can have a major impact on provision of cancer related services. Breast Cancer Res. 2014;16:442.","journal-title":"Breast Cancer Res"},{"key":"1934_CR5","doi-asserted-by":"crossref","unstructured":"Raphael J Verma S, Hewitt P, and Eisen A: The impact of Angelina Jolie's (AJ) story on genetic referral and testing at an academic cancer centre. J Clin Oncol 2014, 32 suppl 26; abstr 44","DOI":"10.1200\/jco.2014.32.26_suppl.44"},{"key":"1934_CR6","unstructured":"Familial breast cancer NICE guidelines CG164 [ http:\/\/www.nice.org.uk\/guidance\/cg164 ]. Accessed June 2015."},{"key":"1934_CR7","unstructured":"Burton H: Genetics and mainstream medicine.\u2009PHG Foundation. 2011: ISBN\u00a0978-1-907198-07-6. http:\/\/www.phgfoundation.org\/file\/7962\/ ."},{"key":"1934_CR8","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/humu.20880","volume":"29","author":"SE Plon","year":"2008","unstructured":"Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, et al. Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat. 2008;29:1282\u201391. doi: 10.1002\/humu.20880 .","journal-title":"Hum Mutat"},{"issue":"8","key":"1934_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/jmedgenet-2012-101037","volume":"49","author":"AB Spurdle","year":"2012","unstructured":"Spurdle AB, Whiley PJ, Thompson B, Feng B, Healey S, Brown MA, et al. BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk. J Med Genet. 2012;49(8):525\u201332.","journal-title":"J Med Genet"},{"key":"1934_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1634\/theoncologist.2012-0452","volume":"18","author":"NM Lindor","year":"2013","unstructured":"Lindor NM, Goldgar DE, Tavtigian SV, Plon SE, Couch FJ. BRCA1\/2\u00a0sequence\u00a0variants\u00a0of uncertain significance: a primer for providers to assist in discussions and in medical management. Oncologist. 2013;18:518\u201324.","journal-title":"Oncologist"},{"key":"1934_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1524-4741.2010.01055.x","volume":"17","author":"K Ready","year":"2011","unstructured":"Ready K, Gutierrez-Barrera AM. Amos et al: Cancer risk management decisions in women with BRCA1 or 2 variants of uncertain significance. Breast J. 2011;17:210\u20132.","journal-title":"Breast J"},{"key":"1934_CR12","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1086\/521032","volume":"81","author":"DF Easton","year":"2007","unstructured":"Easton DF, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, Allen-Brady K, et al. A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in\u00a0the BRCA1\u00a0and\u00a0BRCA2\u00a0Breast Cancer\u2013Predisposition Genes. Am J Hum Genet. 2007;81:873\u201383.","journal-title":"Am J Hum Genet"},{"key":"1934_CR13","unstructured":"Practice Guidelines for the Evaluation of Pathogenicity and the Reporting of Sequence Variants in Clinical Molecular Genetics. [ http:\/\/www.acgs.uk.com\/media\/774853\/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf ]. Accessed June 2015."},{"key":"1934_CR14","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/cge.12097","volume":"84","author":"JO Culver","year":"2013","unstructured":"Culver JO, Brinkerhoff CD, Clague J, Yang K, Singh KE, Sand SR, et al. Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress. Clin Genet. 2013;84:464\u201372. doi: 10.1111\/cge.12097 .","journal-title":"Clin Genet"},{"key":"1934_CR15","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1023\/A:1008319114278","volume":"11","author":"M Escher","year":"2000","unstructured":"Escher M, Sappino AP. Primary Care physicians\u2019 knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol. 2000;11:1131\u20135.","journal-title":"Ann Oncol"},{"key":"1934_CR16","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1365-2354.2005.00574.x","volume":"14","author":"A Ardern-Jones","year":"2005","unstructured":"Ardern-Jones A, Kenen R, Eeles R. Too much, too soon? Patients and health professionals\u2019 views concerning the impact of genetic testing at the time of breast cancer diagnosis in women aged under the age of 40. Eur J Cancer Care. 2005;14:272\u201381.","journal-title":"Eur J Cancer Care"},{"key":"1934_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2354.2008.01065.x","volume":"19","author":"E Riel Van","year":"2010","unstructured":"Van Riel E, Warlam-Rodenhuis CC, Verhoef S, Rutgers EJTH, Ausems MGEM. BRCA testing of breast cancer patients: medical specialists\u2019 referral patterns, knowledge and attitudes to genetic testing. Eur J Cancer. 2010;19:369\u201376.","journal-title":"Eur J Cancer"},{"key":"1934_CR18","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.1200\/JCO.2008.17.8053","volume":"26","author":"N Keating","year":"2008","unstructured":"Keating N, Stoeckert KA, Regan MM, DiGianni L, Garber JE. Physicians\u2018Experiences with BRCA 1\/2 testing in Community Settings. JCO. 2008;26:5789\u201396.","journal-title":"JCO"},{"key":"1934_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/01.GIM.0000055198.63593.32","volume":"5","author":"T Doksum","year":"2003","unstructured":"Doksum T, Berhardt BA, Holtzman NA. Does knowledge about the genetics of breast cancer differ between nongenetists physicians who do or do not discuss or order BRCA testing? Genet Med. 2003;5:99\u2013105.","journal-title":"Genet Med"},{"key":"1934_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/10906570260199357","volume":"6","author":"N Petrucelli","year":"2002","unstructured":"Petrucelli N, Lazebnik N, Huelsman KM, Lazebnik RS. Clinical Interpretation and Recommendations for Patients with a Variant of Uncertain Significance in BRCA1 or BRCA2: A survey of Genetic Counselling Practice. Genet Test. 2002;6:107\u201313.","journal-title":"Genet Test"},{"issue":"Suppl 8","key":"1934_CR21","doi-asserted-by":"publisher","first-page":"viii69","DOI":"10.1093\/annonc\/mdt312","volume":"24","author":"S Richter","year":"2013","unstructured":"Richter S, Haroun I, Graham TC, Eisen A, Kiss A, Warner E. Variants of unknown significance in\u00a0BRCA\u00a0testing: impact on risk perception, worry, prevention and counseling. Ann Oncol. 2013;24 Suppl 8:viii69\u201374.","journal-title":"Ann Oncol"},{"key":"1934_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/humu.21628","volume":"33","author":"AB Spurdle","year":"2012","unstructured":"Spurdle AB, Healey S, Devereau A, Hogervorst FBL, Monteiro ANA, Nathanson KL, et al. ENIGMA\u2014Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in\u00a0BRCA1\u00a0and\u00a0BRCA2\u00a0genes. Hum Mutat. 2012;33:2\u20137.","journal-title":"Hum Mutat"},{"issue":"2","key":"1934_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/GIM.0b013e318207f564","volume":"13","author":"SE Plon","year":"2011","unstructured":"Plon SE, Cooper HP, Parks B, Dhar S, Kelly PA, Weinberg AD, et al. Genetic Testing and Cancer Risk Management Recommendations by Physicians for At-Risk Relatives. Genet Med. 2011;13(2):148\u201354.","journal-title":"Genet Med"},{"key":"1934_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.ejhg.5201379","volume":"13","author":"GR Vink","year":"2005","unstructured":"Vink GR, Asperen CJ, Devilee P, Breuning MH, Bakker E. Unclassified variants in disease-causing genes: nonuniformity of genetic testing and counselling, a proposal for guidelines. Eur J Hum Genet. 2005;13:525\u20137.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"1934_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/humu.21627","volume":"33","author":"NM Lindor","year":"2012","unstructured":"Lindor NM, Guidugli L, Wang X, Vallee MP, Monteiro ANA, Tavtigian S, et al. A Review of a Multifactorial Probability-Based Model for Classification of BRCA1 and BRCA2 Variants of Uncertain Significance (VUS). Hum Mutat. 2012;33(1):8\u201321.","journal-title":"Hum Mutat"},{"key":"1934_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201323.","journal-title":"Genet Med"},{"issue":"supp1","key":"1934_CR27","doi-asserted-by":"publisher","first-page":"i18","DOI":"10.1093\/annonc\/mdq661","volume":"22","author":"P Radice","year":"2011","unstructured":"Radice P, De Summa S, Caleca L, Tommasi S. Unclassified variants in BRCA genes: guidleines for interpretation. Ann Oncol. 2011;22(supp1):i18\u201323.","journal-title":"Ann Oncol"},{"issue":"7","key":"1934_CR28","first-page":"413","volume":"74","author":"KL Brierley","year":"2010","unstructured":"Brierley KL, Campfield D, Ducaine W, Dohany L, Donenberg T, Shannon K, et al. Errors\u00a0in delivery of cancer genetics services: implications for practice. Conn Med. 2010;74(7):413\u201323.","journal-title":"Conn Med"},{"issue":"4","key":"1934_CR29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/PPO.0b013e3182609490","volume":"18","author":"KL Brierley","year":"2012","unstructured":"Brierley KL, Blouch E, Cogswell W, Homer JP, Pencarinha D, Stanislaw CL, et al. Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications. Cancer J. 2012;18(4):303\u20139.","journal-title":"Cancer J"},{"issue":"12","key":"1934_CR30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/GIM.0b013e318226fc15","volume":"13","author":"ML Murray","year":"2011","unstructured":"Murray ML, Cerrato F, Bennett RL, Jarvik GP. Follow-up of carriers of BRCA1 and BRCA2 variants of unknown significance: variant reclassification and surgical decisions. Genet Med. 2011;13(12):998\u20131005.","journal-title":"Genet Med"},{"key":"1934_CR31","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/pon.1311","volume":"17","author":"J Vos","year":"2008","unstructured":"Vos J, Otten W, van Asperen C, Jansen A, Menko F, Tibben A. The counsellees\u2019 view of an unclassified variant in BRCA1\/2: recall, interpretation, and impact on life. Psycho-Oncology. 2008;17:822\u201330. doi: 10.1002\/pon.1311 .","journal-title":"Psycho-Oncology"},{"key":"1934_CR32","unstructured":"GTEOC - Genetic Testing in Epithelial Ovarian Cancer [ http:\/\/public.ukcrn.org.uk\/search\/StudyDetail.aspx?StudyID=13223 ]. Accessed June 2015."},{"key":"1934_CR33","unstructured":"NCRN - 2802 OlympiAD Olaparib vs Physician's Choice in BRCA mutated metastatic breast cancer [ http:\/\/public.ukcrn.org.uk\/Search\/StudyDetail.aspx?StudyID=16109 ]. Accesed June 2015."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1934-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-015-1934-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1934-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T22:57:46Z","timestamp":1567378666000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-015-1934-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,25]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1934"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1934-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,25]]},"article-number":"936"}}